BEGIN:VCALENDAR VERSION:2.0 PRODID:-//NextConsensus//Registered forecast deadlines//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-WR-CALNAME:NextConsensus registered forecast deadlines X-WR-CALDESC:Event deadlines of registered forecasts. Dates\, names\, and l inks only. REFRESH-INTERVAL;VALUE=DURATION:P1D X-PUBLISHED-TTL:PT24H BEGIN:VEVENT UID:ff-007@nextconsensus.com DTSTAMP:20261006T000000Z DTSTART;VALUE=DATE:20261026 DTEND;VALUE=DATE:20261027 SUMMARY:FF-007 deadline: Bepirovirsen · hepatitis B approval DESCRIPTION:Registered forecast FF-007 (FDA)\, Bepirovirsen · hepatitis B approval. It asks whether this happens by 2026-10-26. The record: https:// nextconsensus.com/forecast/ff-007/ URL:https://nextconsensus.com/forecast/ff-007/ CATEGORIES:Registered forecast,FDA TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:ff-016@nextconsensus.com DTSTAMP:20261006T000000Z DTSTART;VALUE=DATE:20261028 DTEND;VALUE=DATE:20261029 SUMMARY:FF-016 deadline: Epcoritamab combination · guidance publication DESCRIPTION:Registered forecast FF-016 (NICE)\, Epcoritamab combination · guidance publication. It asks whether this happens by 2026-10-28. The reco rd: https://nextconsensus.com/forecast/ff-016/ URL:https://nextconsensus.com/forecast/ff-016/ CATEGORIES:Registered forecast,NICE TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:ff-010@nextconsensus.com DTSTAMP:20261006T000000Z DTSTART;VALUE=DATE:20261030 DTEND;VALUE=DATE:20261031 SUMMARY:FF-010 deadline: INO-3107 · papillomatosis approval DESCRIPTION:Registered forecast FF-010 (FDA)\, INO-3107 · papillomatosis a pproval. It asks whether this happens by 2026-10-30. The record: https://n extconsensus.com/forecast/ff-010/ URL:https://nextconsensus.com/forecast/ff-010/ CATEGORIES:Registered forecast,FDA TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:ff-012@nextconsensus.com DTSTAMP:20261006T000000Z DTSTART;VALUE=DATE:20261101 DTEND;VALUE=DATE:20261102 SUMMARY:FF-012 deadline: Mitapivat · sickle cell supplement approval DESCRIPTION:Registered forecast FF-012 (FDA)\, Mitapivat · sickle cell sup plement approval. It asks whether this happens by 2026-11-01. The record: https://nextconsensus.com/forecast/ff-012/ URL:https://nextconsensus.com/forecast/ff-012/ CATEGORIES:Registered forecast,FDA TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:ff-017@nextconsensus.com DTSTAMP:20261006T000000Z DTSTART;VALUE=DATE:20261103 DTEND;VALUE=DATE:20261104 SUMMARY:FF-017 deadline: Inavolisib combination · guidance publication DESCRIPTION:Registered forecast FF-017 (NICE)\, Inavolisib combination · g uidance publication. It asks whether this happens by 2026-11-03. The recor d: https://nextconsensus.com/forecast/ff-017/ URL:https://nextconsensus.com/forecast/ff-017/ CATEGORIES:Registered forecast,NICE TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:ff-019@nextconsensus.com DTSTAMP:20261006T000000Z DTSTART;VALUE=DATE:20261111 DTEND;VALUE=DATE:20261112 SUMMARY:FF-019 deadline: Nivolumab + ipilimumab · guidance publication DESCRIPTION:Registered forecast FF-019 (NICE)\, Nivolumab + ipilimumab · g uidance publication. It asks whether this happens by 2026-11-11. The recor d: https://nextconsensus.com/forecast/ff-019/ URL:https://nextconsensus.com/forecast/ff-019/ CATEGORIES:Registered forecast,NICE TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:ff-022@nextconsensus.com DTSTAMP:20261006T000000Z DTSTART;VALUE=DATE:20261112 DTEND;VALUE=DATE:20261113 SUMMARY:FF-022 deadline: Zuranolone · guidance publication DESCRIPTION:Registered forecast FF-022 (NICE)\, Zuranolone · guidance publ ication. It asks whether this happens by 2026-11-12. The record: https://n extconsensus.com/forecast/ff-022/ URL:https://nextconsensus.com/forecast/ff-022/ CATEGORIES:Registered forecast,NICE TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:ff-005@nextconsensus.com DTSTAMP:20261006T000000Z DTSTART;VALUE=DATE:20261114 DTEND;VALUE=DATE:20261115 SUMMARY:FF-005 deadline: Aficamten · MAPLE-HCM supplement approval DESCRIPTION:Registered forecast FF-005 (FDA)\, Aficamten · MAPLE-HCM suppl ement approval. It asks whether this happens by 2026-11-14. The record: ht tps://nextconsensus.com/forecast/ff-005/ URL:https://nextconsensus.com/forecast/ff-005/ CATEGORIES:Registered forecast,FDA TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:ff-009@nextconsensus.com DTSTAMP:20261006T000000Z DTSTART;VALUE=DATE:20261114 DTEND;VALUE=DATE:20261115 SUMMARY:FF-009 deadline: IGALMI · at-home supplement approval DESCRIPTION:Registered forecast FF-009 (FDA)\, IGALMI · at-home supplement approval. It asks whether this happens by 2026-11-14. The record: https:/ /nextconsensus.com/forecast/ff-009/ URL:https://nextconsensus.com/forecast/ff-009/ CATEGORIES:Registered forecast,FDA TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:ff-011@nextconsensus.com DTSTAMP:20261006T000000Z DTSTART;VALUE=DATE:20261114 DTEND;VALUE=DATE:20261115 SUMMARY:FF-011 deadline: Ivonescimab · post-TKI NSCLC approval DESCRIPTION:Registered forecast FF-011 (FDA)\, Ivonescimab · post-TKI NSCL C approval. It asks whether this happens by 2026-11-14. The record: https: //nextconsensus.com/forecast/ff-011/ URL:https://nextconsensus.com/forecast/ff-011/ CATEGORIES:Registered forecast,FDA TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:ff-014@nextconsensus.com DTSTAMP:20261006T000000Z DTSTART;VALUE=DATE:20261118 DTEND;VALUE=DATE:20261119 SUMMARY:FF-014 deadline: Beremagene geperpavec · guidance publication DESCRIPTION:Registered forecast FF-014 (NICE)\, Beremagene geperpavec · gu idance publication. It asks whether this happens by 2026-11-18. The record : https://nextconsensus.com/forecast/ff-014/ URL:https://nextconsensus.com/forecast/ff-014/ CATEGORIES:Registered forecast,NICE TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:ff-015@nextconsensus.com DTSTAMP:20261006T000000Z DTSTART;VALUE=DATE:20261118 DTEND;VALUE=DATE:20261119 SUMMARY:FF-015 deadline: Efgartigimod · CIDP guidance publication DESCRIPTION:Registered forecast FF-015 (NICE)\, Efgartigimod · CIDP guidan ce publication. It asks whether this happens by 2026-11-18. The record: ht tps://nextconsensus.com/forecast/ff-015/ URL:https://nextconsensus.com/forecast/ff-015/ CATEGORIES:Registered forecast,NICE TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:ff-018@nextconsensus.com DTSTAMP:20261006T000000Z DTSTART;VALUE=DATE:20261118 DTEND;VALUE=DATE:20261119 SUMMARY:FF-018 deadline: Larotrectinib · guidance publication DESCRIPTION:Registered forecast FF-018 (NICE)\, Larotrectinib · guidance p ublication. It asks whether this happens by 2026-11-18. The record: https: //nextconsensus.com/forecast/ff-018/ URL:https://nextconsensus.com/forecast/ff-018/ CATEGORIES:Registered forecast,NICE TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:ff-020@nextconsensus.com DTSTAMP:20261006T000000Z DTSTART;VALUE=DATE:20261118 DTEND;VALUE=DATE:20261119 SUMMARY:FF-020 deadline: Orforglipron · guidance publication DESCRIPTION:Registered forecast FF-020 (NICE)\, Orforglipron · guidance pu blication. It asks whether this happens by 2026-11-18. The record: https:/ /nextconsensus.com/forecast/ff-020/ URL:https://nextconsensus.com/forecast/ff-020/ CATEGORIES:Registered forecast,NICE TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:ff-021@nextconsensus.com DTSTAMP:20261006T000000Z DTSTART;VALUE=DATE:20261118 DTEND;VALUE=DATE:20261119 SUMMARY:FF-021 deadline: Pembrolizumab combination · guidance publication DESCRIPTION:Registered forecast FF-021 (NICE)\, Pembrolizumab combination · guidance publication. It asks whether this happens by 2026-11-18. The r ecord: https://nextconsensus.com/forecast/ff-021/ URL:https://nextconsensus.com/forecast/ff-021/ CATEGORIES:Registered forecast,NICE TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:ff-008@nextconsensus.com DTSTAMP:20261006T000000Z DTSTART;VALUE=DATE:20261122 DTEND;VALUE=DATE:20261123 SUMMARY:FF-008 deadline: Deramiocel · Duchenne approval DESCRIPTION:Registered forecast FF-008 (FDA)\, Deramiocel · Duchenne appro val. It asks whether this happens by 2026-11-22. The record: https://nextc onsensus.com/forecast/ff-008/ URL:https://nextconsensus.com/forecast/ff-008/ CATEGORIES:Registered forecast,FDA TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:ff-013@nextconsensus.com DTSTAMP:20261006T000000Z DTSTART;VALUE=DATE:20261122 DTEND;VALUE=DATE:20261123 SUMMARY:FF-013 deadline: Molgramostim · aPAP approval DESCRIPTION:Registered forecast FF-013 (FDA)\, Molgramostim · aPAP approva l. It asks whether this happens by 2026-11-22. The record: https://nextcon sensus.com/forecast/ff-013/ URL:https://nextconsensus.com/forecast/ff-013/ CATEGORIES:Registered forecast,FDA TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:ff-027@nextconsensus.com DTSTAMP:20261006T000000Z DTSTART;VALUE=DATE:20261125 DTEND;VALUE=DATE:20261126 SUMMARY:FF-027 deadline: Venglustat · type 3 Gaucher disease approval DESCRIPTION:Registered forecast FF-027 (FDA)\, Venglustat · type 3 Gaucher disease approval. It asks whether this happens by 2026-11-25. The record: https://nextconsensus.com/forecast/ff-027/ URL:https://nextconsensus.com/forecast/ff-027/ CATEGORIES:Registered forecast,FDA TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:ff-028@nextconsensus.com DTSTAMP:20261006T000000Z DTSTART;VALUE=DATE:20261125 DTEND;VALUE=DATE:20261126 SUMMARY:FF-028 deadline: Obicetrapib · hypercholesterolaemia guidance publ ication DESCRIPTION:Registered forecast FF-028 (NICE)\, Obicetrapib · hypercholest erolaemia guidance publication. It asks whether this happens by 2026-11-25 . The record: https://nextconsensus.com/forecast/ff-028/ URL:https://nextconsensus.com/forecast/ff-028/ CATEGORIES:Registered forecast,NICE TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:ff-029@nextconsensus.com DTSTAMP:20261006T000000Z DTSTART;VALUE=DATE:20261125 DTEND;VALUE=DATE:20261126 SUMMARY:FF-029 deadline: Polihexanide · acanthamoeba keratitis guidance pu blication DESCRIPTION:Registered forecast FF-029 (NICE)\, Polihexanide · acanthamoeb a keratitis guidance publication. It asks whether this happens by 2026-11- 25. The record: https://nextconsensus.com/forecast/ff-029/ URL:https://nextconsensus.com/forecast/ff-029/ CATEGORIES:Registered forecast,NICE TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:ff-006@nextconsensus.com DTSTAMP:20261006T000000Z DTSTART;VALUE=DATE:20261127 DTEND;VALUE=DATE:20261128 SUMMARY:FF-006 deadline: BBP-418 · muscular dystrophy approval DESCRIPTION:Registered forecast FF-006 (FDA)\, BBP-418 · muscular dystroph y approval. It asks whether this happens by 2026-11-27. The record: https: //nextconsensus.com/forecast/ff-006/ URL:https://nextconsensus.com/forecast/ff-006/ CATEGORIES:Registered forecast,FDA TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:ff-025@nextconsensus.com DTSTAMP:20261006T000000Z DTSTART;VALUE=DATE:20261127 DTEND;VALUE=DATE:20261128 SUMMARY:FF-025 deadline: Neladalkib · ALK-positive NSCLC approval DESCRIPTION:Registered forecast FF-025 (FDA)\, Neladalkib · ALK-positive N SCLC approval. It asks whether this happens by 2026-11-27. The record: htt ps://nextconsensus.com/forecast/ff-025/ URL:https://nextconsensus.com/forecast/ff-025/ CATEGORIES:Registered forecast,FDA TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:ff-024@nextconsensus.com DTSTAMP:20261006T000000Z DTSTART;VALUE=DATE:20261128 DTEND;VALUE=DATE:20261129 SUMMARY:FF-024 deadline: D-PLEX100 · colorectal surgical site infection ap proval DESCRIPTION:Registered forecast FF-024 (FDA)\, D-PLEX100 · colorectal surg ical site infection approval. It asks whether this happens by 2026-11-28. The record: https://nextconsensus.com/forecast/ff-024/ URL:https://nextconsensus.com/forecast/ff-024/ CATEGORIES:Registered forecast,FDA TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:ff-023@nextconsensus.com DTSTAMP:20261006T000000Z DTSTART;VALUE=DATE:20261130 DTEND;VALUE=DATE:20261201 SUMMARY:FF-023 deadline: Bezuclastinib · GIST approval DESCRIPTION:Registered forecast FF-023 (FDA)\, Bezuclastinib · GIST approv al. It asks whether this happens by 2026-11-30. The record: https://nextco nsensus.com/forecast/ff-023/ URL:https://nextconsensus.com/forecast/ff-023/ CATEGORIES:Registered forecast,FDA TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:ff-026@nextconsensus.com DTSTAMP:20261006T000000Z DTSTART;VALUE=DATE:20261130 DTEND;VALUE=DATE:20261201 SUMMARY:FF-026 deadline: Povetacicept · IgA nephropathy approval DESCRIPTION:Registered forecast FF-026 (FDA)\, Povetacicept · IgA nephropa thy approval. It asks whether this happens by 2026-11-30. The record: http s://nextconsensus.com/forecast/ff-026/ URL:https://nextconsensus.com/forecast/ff-026/ CATEGORIES:Registered forecast,FDA TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:ff-003@nextconsensus.com DTSTAMP:20261006T000000Z DTSTART;VALUE=DATE:20270331 DTEND;VALUE=DATE:20270401 SUMMARY:FF-003 deadline: Sunvozertinib · first-line approval by March DESCRIPTION:Registered forecast FF-003 (FDA)\, Sunvozertinib · first-line approval by March. It asks whether this happens by 2027-03-31. The record: https://nextconsensus.com/forecast/ff-003/ URL:https://nextconsensus.com/forecast/ff-003/ CATEGORIES:Registered forecast,FDA TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:ff-001@nextconsensus.com DTSTAMP:20261006T000000Z DTSTART;VALUE=DATE:20270731 DTEND;VALUE=DATE:20270801 SUMMARY:FF-001 deadline: Sunvozertinib · first-line guideline listing DESCRIPTION:Registered forecast FF-001 (NCCN)\, Sunvozertinib · first-line guideline listing. It asks whether this happens by 2027-07-31. The record : https://nextconsensus.com/forecast/ff-001/ URL:https://nextconsensus.com/forecast/ff-001/ CATEGORIES:Registered forecast,NCCN TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:ff-002@nextconsensus.com DTSTAMP:20261006T000000Z DTSTART;VALUE=DATE:20270731 DTEND;VALUE=DATE:20270801 SUMMARY:FF-002 deadline: Sunvozertinib · first-line approval DESCRIPTION:Registered forecast FF-002 (FDA)\, Sunvozertinib · first-line approval. It asks whether this happens by 2027-07-31. The record: https:// nextconsensus.com/forecast/ff-002/ URL:https://nextconsensus.com/forecast/ff-002/ CATEGORIES:Registered forecast,FDA TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:ff-004@nextconsensus.com DTSTAMP:20261006T000000Z DTSTART;VALUE=DATE:20270731 DTEND;VALUE=DATE:20270801 SUMMARY:FF-004 deadline: Sunvozertinib · FDA approval before NCCN listing DESCRIPTION:Registered forecast FF-004 (NCCN)\, Sunvozertinib · FDA approv al before NCCN listing. It asks whether this happens by 2027-07-31. The re cord: https://nextconsensus.com/forecast/ff-004/ URL:https://nextconsensus.com/forecast/ff-004/ CATEGORIES:Registered forecast,NCCN TRANSP:TRANSPARENT END:VEVENT END:VCALENDAR